EZH2 and lung adenocarcinoma: Furthermore, LINC00152 inhibited the expression of tumour suppressor IL-24 by directly interacting with EZH2, which significantly increased the levels of Bcl-xl proteins, thus inhibiting apoptosis and promoting cell growth in lung adenocarcinoma [29].